$0.1300
0.006004.84%
At close: -
$0.0905
-0.04-30.38%
After Hours: Apr 11, 6:09 PM EDT
Comments
Loading...
Drugs Made In America Acquisition Corp. - Rights Stock Guidance
DMAARNASDAQ
Drugs Made In America Acquisition Corp. - Rights Stock Guidance | NASDAQ:DMAAR | Benzinga
Drugs Made In America Acquisition Corp. - Rights issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drugs Made In America Acquisition Corp. - Rights (DMAAR) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Drugs Made In America Acquisition Corp. - Rights (DMAAR)?
There have been no specific sales or earnings guidance reported for Drugs Made In America Acquisition Corp. - Rights in recent months.
Browse guidance and forecast on all stocks.
